Piglet Castration: Welfare and Alternatives

Surgical castration of male piglets is performed to prevent boar taint in pork but causes significant pain and welfare harm that is driving adoption of alternatives.

Key Facts

Approximately 100 million male piglets in Europe and 60 million in the US undergo surgical castration annually
Castration without analgesia causes acute pain evidenced by vocalizations, struggling, and cortisol elevation
Post-operative pain persists for 24-48 hours after the procedure
Immunocastration using Improvac vaccine is approved in over 60 countries as a welfare-friendly alternative
Genetic selection and management changes can reduce boar taint risk in entire male production

Welfare Considerations

Surgical piglet castration without anesthesia represents one of the most widespread welfare-compromising practices in commercial animal production. The acute pain response is well-documented through grimace scales, ultrasonic vocalizations, and neuroendocrine stress markers. Post-operative pain during the 24-48 hour recovery period is typically untreated despite being substantial. Immunocastration eliminates the need for surgical castration entirely, with equal or better boar taint prevention and equivalent production outcomes. The European Declaration on alternatives to surgical castration targeted 2018 for anesthesia requirements and alternatives, goals that have only partially been achieved.

What You Can Do

Support food companies committed to analgesia for all piglet castration in their supply chains
Choose pork from farms using immunocastration or entire male production systems
Advocate for national legislation requiring anesthesia for all piglet castration
Donate to research accelerating genetic selection for low taint risk in entire male pigs